GRDI funding has enabled researchers at the Canadian Food Inspection Agency (CFIA) to routinely identify antimicrobial resistance (AMR) genes in their genetic analysis of pathogenic bacteria such as disease-causing types of E. coli and Salmonella.
A key to the successful outcomes of the Genomics R&D Initiative has been to ensure Canadian researchers have the tools they need to explore the almost infinite potential of genomics to enhance the health, safety and economic well-being of Canadians.